← Back to Clinical Trials
Recruiting NCT07001111

NCT07001111 Investigation of the Effectiveness of Kinesiological Taping in Cubital Tunnel Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07001111
Status Recruiting
Phase
Sponsor Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Condition Cubital Tunnel Syndrome
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2025-04-21
Primary Completion 2025-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
kinesio tapingUlnar nerve mobilization exerciseSham (No Treatment)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2025-04-21 with a primary completion date of 2025-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effect of kinesiological taping, applied in addition to exercise, on clinical symptoms in patients diagnosed with Cubital Tunnel Syndrome. The patients will be randomized into three groups (exercise, exercise + kinesiological taping, exercise + sham taping) and will be evaluated at the 1st and 3rd months after a 3-week treatment period.

Eligibility Criteria

Inclusion Criteria: * Aged between 18 and 65 years * Patients with at least 3 points of pain according to the Numeric Rating Scale (NRS) * Patients diagnosed with Cubital Tunnel Syndrome via Electroneuromyography (ENMG) * Literate * Willing to consent to participate in the study Exclusion Criteria: * Having any secondary entrapment neuropathy such as diabetes, inflammatory arthritis, or hypothyroidism * Pregnancy * Active cancer presence * Skin infection, burns, wounds, or scars on the forearm * History of elbow trauma * Cervical radiculopathy or brachial plexopathy * Polyneuropathy * Having previously undergone Cubital Tunnel decompression surgery * Having received a corticosteroid injection into the Cubital Tunnel within the last 3 months * Illiterate * Not consenting to participate in the study

Contact & Investigator

Central Contact

Aysu Girgin Gulesen

✉ draysugirgin@gmail.com

📞 (0216) 542 20 00

Frequently Asked Questions

Who can join the NCT07001111 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cubital Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07001111 currently recruiting?

Yes, NCT07001111 is actively recruiting participants. Contact the research team at draysugirgin@gmail.com for enrollment information.

Where is the NCT07001111 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07001111 clinical trial?

NCT07001111 is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology